Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model

Molecular Carcinogenesis(2024)10.1002/mc.23827Source: DataRank Database

Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model is a research paper published in Molecular Carcinogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.91)OA: bronzeTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Ranjit Ray ORCID,Ratna B. Ray ORCID,Yuki Haga ORCID

Live enrichment

PubMed:39377735 OpenAlex:https://openalex.org/W4403217670

National Institutes of Health

This study was supported by National Institutes of Health.

FWCI

0.91

Citation Percentile

0.8%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mc.23827

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mc.23827

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23827

journalhttps://doi.org/10.1002/mc.23827

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39377735

Fields of Study

Cancer-related Molecular PathwaysDrug Transport and Resistance MechanismsUbiquitin and proteasome pathways

MeSH Terms

AnilidesAnimalsAntineoplastic Combined Chemotherapy ProtocolsCell CycleCarcinoma, HepatocellularHumansLiver NeoplasmsMice, NudePteridinesPyridinesTriazinesApoptosisXenograft Model Antitumor AssaysCell Line, TumorProtein Kinase InhibitorsCell ProliferationMice

Keywords

Cancer researchCabozantinibCombination therapyCell cycleBiologyApoptosisCell cycle checkpointDownregulation and upregulationCancerHepatocellular carcinomaCell growthPharmacologyBiochemistryKinase InhibitorsGrowth Inhibition Mechanisms

Sustainable Development Goals

SDG 0: Good health and well-being